Arthneeti

ERIS Lifescience — promoter holding and stake value

Pharmaceuticals & Biotechnology

The promoter group of ERIS Lifescience holds 54.74% of the company. At a market capitalisation of ₹16.34k cr, that holding is worth ₹8.94k cr.

Promoter stake

54.74%

Value of holding

₹8.94k cr

Market cap

₹16.34k cr

Stake change

-1.19%

Promoter stake, quarter by quarter

QuarterHoldingStake %Pledged
Q2-2017
55.93%—
Q3-2017
55.93%—
Q4-2017
55.93%—
Q1-2018
55.93%—
Q2-2018
55.93%—
Q3-2018
55.92%—
Q4-2018
56.04%—
Q1-2019
56.10%—
Q2-2019
56.23%—
Q3-2019
56.23%—
Q4-2019
56.23%—
Q1-2020
55.55%—
Q2-2020
55.55%—
Q3-2020
54.08%—
Q4-2020
54.23%—
Q1-2021
54.13%—
Q2-2021
52.69%—
Q3-2021
52.68%—
Q4-2021
52.66%—
Q1-2022
52.66%—
Q2-2022
52.30%—
Q3-2022
52.29%—
Q4-2022
52.70%—
Q1-2023
52.86%—
Q2-2023
52.86%—
Q3-2023
54.91%—
Q4-2023
54.90%—
Q1-2024
54.90%—
Q2-2024
54.88%—
Q3-2024
54.87%—
Q4-2024
54.86%—
Q1-2025
54.85%—
Q2-2025
54.83%—
Q3-2025
54.85%—
Q4-2025
54.85%—
Q1-2026
53.92%—
Q2-2026
54.14%—
Q3-2026
54.74%—

Promoter holdings in Pharmaceuticals & Biotechnology

What this figure is, and is not

The value shown is ERIS Lifescience's disclosed promoter shareholding multiplied by its current market capitalisation. The shareholding percentage comes from the quarterly pattern filed with the exchanges; the market cap moves daily, so this value moves daily.

A promoter group is usually a family, trust or holding company rather than one individual, and this figure covers only this one listed company. It is not an estimate of any person's net worth, and it excludes any other assets, holdings or liabilities.